Published in J Virol on August 01, 1992
Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02
Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol (2001) 7.82
A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res (1995) 7.08
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol (1996) 6.62
Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol (1993) 5.30
Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol (1994) 4.28
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A (2002) 4.14
An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol (2000) 4.05
Virus maturation by budding. Microbiol Mol Biol Rev (1998) 3.78
Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J (2004) 3.77
The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J Virol (1996) 3.22
Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Natl Acad Sci U S A (1998) 3.00
Identification of novel stress-induced genes downstream of chop. EMBO J (1998) 2.93
The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol (1996) 2.87
Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol (1995) 2.59
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol (1995) 2.35
Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci U S A (2007) 2.30
Inhibition of a constitutive translation initiation factor 2alpha phosphatase, CReP, promotes survival of stressed cells. J Cell Biol (2003) 2.15
Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J Virol (2004) 2.06
Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma. Mol Cell Biol (1996) 1.84
Reawakening retrocyclins: ancestral human defensins active against HIV-1. PLoS Biol (2009) 1.80
Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci U S A (1995) 1.80
Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. J Virol (2003) 1.79
Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J Virol (1994) 1.75
Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response. J Virol (2002) 1.69
An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J Virol (1999) 1.61
Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells. J Virol (2000) 1.55
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs. J Virol (2000) 1.54
The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion. Mol Cell Biol (2003) 1.52
Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci U S A (1999) 1.48
Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection. Mol Biol Cell (1999) 1.47
Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope. J Virol (2001) 1.45
Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection. J Virol (1997) 1.40
The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death. Proc Natl Acad Sci U S A (1996) 1.38
Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein. J Virol (1998) 1.37
Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein. J Virol (2000) 1.33
The central proline of an internal viral fusion peptide serves two important roles. J Virol (2000) 1.33
Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol (2004) 1.31
Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc Natl Acad Sci U S A (1998) 1.30
A method to identify cDNAs based on localization of green fluorescent protein fusion products. Proc Natl Acad Sci U S A (2000) 1.27
3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. J Virol (2000) 1.26
Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci U S A (1995) 1.24
Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope. J Virol (2001) 1.22
Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res (2012) 1.21
Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proc Natl Acad Sci U S A (1998) 1.19
In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J Virol (2000) 1.18
Palmitoylation of either Cys-3 or Cys-5 is required for the biological activity of the Lck tyrosine protein kinase. Mol Cell Biol (1995) 1.17
Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets. Protein Sci (2014) 1.16
Isolation of cell lines that show novel, murine leukemia virus-specific blocks to early steps of retroviral replication. J Virol (2005) 1.16
Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol (1999) 1.15
Activation of Src family members is not required for the platelet-derived growth factor beta receptor to initiate mitogenesis. Mol Cell Biol (1998) 1.14
Synchronized infection of cell cultures by magnetically controlled virus. J Virol (2005) 1.14
Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors. Proc Natl Acad Sci U S A (1996) 1.14
The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag gene. J Virol (1995) 1.11
Regulation of neuronal P53 activity by CXCR 4. Mol Cell Neurosci (2005) 1.10
The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons. J Neurovirol (2003) 1.10
A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J (1994) 1.09
Apoptotic and antiapoptotic effects of CXCR4: is it a matter of intrinsic efficacy? Implications for HIV neuropathogenesis. AIDS Res Hum Retroviruses (2004) 1.06
Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc Natl Acad Sci U S A (1995) 1.05
A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation. Nucleic Acids Res (2000) 1.03
High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J Virol (1997) 1.03
TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J Virol (1996) 1.02
Selective restriction of Nef-defective human immunodeficiency virus type 1 by a proteasome-dependent mechanism. J Virol (2006) 1.02
Characterization of the steric defense of the HIV-1 gp41 N-trimer region. Protein Sci (2008) 1.01
Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides. Antimicrob Agents Chemother (2013) 1.00
The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors. Retrovirology (2008) 1.00
The host cell sulfonation pathway contributes to retroviral infection at a step coincident with provirus establishment. PLoS Pathog (2008) 0.99
The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. Proc Natl Acad Sci U S A (1998) 0.99
The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration. J Virol (2005) 0.99
Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency. J Virol (2008) 0.99
Conditional expression of the TVA receptor allows clonal analysis of descendents from Cre-expressing progenitor cells. Dev Biol (2011) 0.98
CD2 regulates responsiveness of activated T cells to interleukin 12. J Exp Med (1995) 0.97
Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA. J Virol (2007) 0.97
CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function. J Virol (1999) 0.96
The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo. J Virol (1996) 0.96
Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line. Neoplasia (2000) 0.93
Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Nucleic Acids Res (2005) 0.92
Induction of a secreted protein by the myxoid liposarcoma oncogene. Proc Natl Acad Sci U S A (1999) 0.91
Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence. J Virol (2008) 0.90
Properties of wild-type, C-terminally truncated, and chimeric maedi-visna virus glycoprotein and putative pseudotyping of retroviral vector particles. J Virol (2001) 0.90
The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections. J Virol (2008) 0.89
Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms. Biochem J (1999) 0.88
Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors. J Virol (1997) 0.88
High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages. J Gen Virol (2010) 0.87
Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release. J Biol Chem (2011) 0.86
Production of high titre helper-free recombinant retroviral vectors by lipofection. Nucleic Acids Res (1994) 0.85
Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate. J Virol (2005) 0.85
E2F-1 has dual roles depending on the cell cycle. Int J Biol Sci (2010) 0.84
CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells. Melanoma Res (2007) 0.83
Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J Virol (1998) 0.83
Evaluation of Tat-encoding bicistronic human immunodeficiency virus type 1 gene transfer vectors in primary canine bone marrow mononuclear cells. J Virol (2002) 0.79
HIV-1 infection is blocked at an early stage in cells devoid of mitochondrial DNA. PLoS One (2013) 0.78
Distinct Particle Morphologies Revealed through Comparative Parallel Analyses of Retrovirus-Like Particles. J Virol (2016) 0.78
A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice. PLoS One (2014) 0.77
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J Virol (1976) 9.33
Expression of human class II major histocompatibility complex antigens using retrovirus vectors. Proc Natl Acad Sci U S A (1987) 4.84
Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell (1990) 4.84
Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol (1991) 4.74
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol (1991) 4.31
Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. DNA (1988) 2.61
Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J Virol (1988) 2.55
Structure and expression of the herpes simplex virus type 2 glycoprotein gB gene. J Virol (1987) 2.52
Human cells infected with retrovirus vectors acquire an endogenous murine provirus. J Virol (1990) 1.65
Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA. Mol Cell Biol (1985) 1.58
Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81
Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol (2000) 14.74
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell (2000) 14.43
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature (1998) 11.41
Signal transduction by lymphocyte antigen receptors. Cell (1994) 10.63
The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell (1985) 7.16
Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (1997) 6.23
Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science (2000) 5.78
PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature (2000) 5.48
A new classification for HIV-1. Nature (1998) 5.30
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol (1997) 5.18
Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J Virol (1990) 5.01
Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell (1990) 4.84
Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol (1991) 4.74
The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev (1998) 4.38
Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med (1999) 4.32
BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol (1991) 4.31
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med (1997) 4.21
Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med (2001) 3.96
The isolation and sequence of the gene encoding T8: a molecule defining functional classes of T lymphocytes. Cell (1985) 3.91
Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol (2001) 3.89
A subset of CD4+ thymocytes selected by MHC class I molecules. Science (1994) 3.87
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol (1999) 3.66
Properties of the depolymerization products of microtubules from mammalian brain. Biochemistry (1974) 3.58
CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int (2006) 3.53
The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature (1988) 3.47
A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med (2001) 3.36
A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell (1994) 3.10
Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med (1997) 2.99
Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol (1998) 2.83
Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell (1991) 2.79
Control of interneuron fate in the developing spinal cord by the progenitor homeodomain protein Dbx1. Neuron (2001) 2.78
Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature (1988) 2.66
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science (1999) 2.45
Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity. J Virol (1993) 2.34
Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J Virol (1992) 2.30
The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest (2001) 2.26
Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity (1995) 2.26
Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes. Cell (1993) 2.25
The structure of the CD4 and CD8 genes. Annu Rev Immunol (1987) 2.25
Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature (1988) 2.25
The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol (2000) 2.22
Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol (1990) 2.21
Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology (1998) 2.20
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science (1993) 2.20
A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature (1990) 2.17
A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell (1993) 2.16
Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells. Immunity (1999) 2.09
The gene encoding the T-cell surface protein T4 is located on human chromosome 12. Proc Natl Acad Sci U S A (1986) 2.08
Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J Virol (1998) 2.03
Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat Genet (2001) 1.95
Retracted Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science (1999) 1.93
Viral receptors of the immunoglobulin superfamily. Cell (1989) 1.90
A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol Cell Biol (1993) 1.89
Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J (1993) 1.86
Regulation of IL-4 expression by activation of individual alleles. Immunity (1998) 1.84
Identification and sequence of a fourth human T cell antigen receptor chain. Nature (1988) 1.81
Unusual intron in the immunoglobulin domain of the newly isolated murine CD4 (L3T4) gene. Nature (1987) 1.78
Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature (1989) 1.76
The regulation of CD4 and CD8 coreceptor gene expression during T cell development. Annu Rev Immunol (1999) 1.72
Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. J Virol (1998) 1.69
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69
The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits. J Cell Biol (1992) 1.67
A second subunit of CD8 is expressed in human T cells. EMBO J (1988) 1.55
Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J Virol (1996) 1.53
Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene. Mol Cell Biol (1991) 1.50
An enhancer that directs lineage-specific expression of CD8 in positively selected thymocytes and mature T cells. Immunity (1997) 1.48
Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN. J Virol (2001) 1.48
Development and function of T cells in mice with a disrupted CD2 gene. EMBO J (1992) 1.46
Multiple developmental stage-specific enhancers regulate CD8 expression in developing thymocytes and in thymus-independent T cells. Immunity (1998) 1.44
Lymphoid tissue inducer cells in intestinal immunity. Curr Top Microbiol Immunol (2006) 1.38
Segmented filamentous bacteria take the stage. Mucosal Immunol (2010) 1.37
Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. Immunity (1994) 1.34
The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins. Virology (1998) 1.33
Insertion of Ia and H-2 alloantigens into model membranes. Proc Natl Acad Sci U S A (1979) 1.31
A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum Mol Genet (1999) 1.24
Characterization of an expressed CD3-associated Ti gamma-chain reveals C gamma domain polymorphism. Nature (1987) 1.23
Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells. J Exp Med (1992) 1.23
Helper T-cell development in the absence of CD4-p56lck association. Nature (1993) 1.22
Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J Exp Med (2000) 1.18
Participation of CD4 coreceptor molecules in T-cell repertoire selection. Nature (1991) 1.18
HIV: master of the host cell. Genome Biol (2001) 1.18
Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus. J Virol (1998) 1.18
Natural resistance to HIV? Nature (1996) 1.15
Alternatively spliced mRNA encodes a secreted form of human CD8 alpha. Characterization of the human CD8 alpha gene. J Immunol (1989) 1.13
Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay. AIDS (1996) 1.13
CD2 regulates the positive selection and function of antigen-specific CD4- CD8+ T cells. Blood (1997) 1.13
Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J Virol (1991) 1.13
Molecular diversity of the human T-gamma constant region genes. Science (1987) 1.09
Human brain glycogen phosphorylase. Cloning, sequence analysis, chromosomal mapping, tissue expression, and comparison with the human liver and muscle isozymes. J Biol Chem (1988) 1.09
Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules. J Virol (1995) 1.07
Glycosylphosphatidylinositol-anchored CD4/Thy-1 chimeric molecules serve as human immunodeficiency virus receptors in human, but not mouse, cells and are modulated by gangliosides. J Virol (1991) 1.02
G protein-coupled receptors in HIV and SIV entry: new perspectives on lentivirus-host interactions and on the utility of animal models. Semin Immunol (1998) 0.97
Corrected CD4 sequence. Cell (1988) 0.96
CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol Cell Biol (1995) 0.96
The thymus leukemia antigen binds human and mouse CD8. J Exp Med (1991) 0.95
The T4 glycoprotein is a cell-surface receptor for the AIDS virus. Cold Spring Harb Symp Quant Biol (1986) 0.95
Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne. J Virol (1999) 0.95